Insider Transactions in Q1 2022 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
693
-1.27%
|
$5,544
$8.73 P/Share
|
|
Mar 11
2022
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
3,384
-1.58%
|
$27,072
$8.73 P/Share
|
|
Mar 11
2022
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
640
-0.96%
|
$5,120
$8.73 P/Share
|
|
Mar 11
2022
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
765
-1.04%
|
$6,120
$8.73 P/Share
|
|
Mar 11
2022
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
481
-0.79%
|
$3,848
$8.73 P/Share
|
|
Mar 11
2022
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
308
-1.13%
|
$2,464
$8.73 P/Share
|
|
Mar 02
2022
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,617
-7.77%
|
$44,936
$8.56 P/Share
|